Home › Funds › GROUPAMA ASSET MANAGMENT › VRTX
GROUPAMA ASSET MANAGMENT position in VRTX
VERTEX PHARMACEUTICALS INC · Health Care
GROUPAMA ASSET MANAGMENT reported holding 188,156 shares of VRTX (VERTEX PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$93.9M, representing 1.23% of its reported portfolio and ranking #23 among its reported holdings. GROUPAMA ASSET MANAGMENT has disclosed VRTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How GROUPAMA ASSET MANAGMENT's VRTX position evolved
GROUPAMA ASSET MANAGMENT first disclosed a stake in VRTX in Q4 2023 at 25,039 shares (US$10.2M). The position peaked in Q2 2026 at 188,156 shares, worth US$93.9M. Across 11 filings, GROUPAMA ASSET MANAGMENT increased the stake 8 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 188,156 shares valued at US$93.9M — an increase of 22,259 shares quarter over quarter.. Notable position changes include a 58% trim in Q1 2024 (shares rose 12% over the following quarter), a 190% increase in Q2 2024 (shares were roughly flat over the following quarter), a 276% increase in Q4 2025 (shares fell 1% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 25.04K | $10.19M | New |
| Q1 2024 | 10.56K | $12.24M | Reduce |
| Q2 2024 | 30.59K | $14.34M | Add |
| Q3 2024 | 34.33K | $12.82M | Add |
| Q4 2024 | 43.48K | $17.36M | Add |
| Q1 2025 | 51.93K | $25.59M | Add |
| Q2 2025 | 61.30K | $27.05M | Add |
| Q3 2025 | 43.38K | $16.99M | Reduce |
| Q4 2025 | 163.14K | $73.96M | Add |
| Q1 2026 | 165.90K | $74.08M | Add |
| Q2 2026 | 188.16K | $93.87M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About VRTX and 13F data
VRTX (VERTEX PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VRTX — the largest reported positions include Capital World Investors (US$12.97B), Capital World Investors (US$12.97B), Capital Research Global Investors (US$9.68B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VRTX
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital World Investors 26.12M sh · $12.97B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Capital Research Global Investors 19.49M sh · $9.68B · Q2 2026
- Invesco Ltd 8.04M sh · $4.00B · Q2 2026
- LOOMIS SAYLES & CO L P 3.92M sh · $1.95B · Q2 2026
- JENNISON ASSOCIATES LLC 3.00M sh · $1.49B · Q2 2026
- ALLIANCEBERNSTEIN L.P. 3.02M sh · $1.35B · Q2 2026
- Clearbridge Investments, LLC 2.34M sh · $1.16B · Q2 2026
- VICTORY CAPITAL MANAGEMENT INC 2.17M sh · $1.08B · Q2 2026
- Janus Henderson Group 2.13M sh · $951.79M · Q1 2026
More on GROUPAMA ASSET MANAGMENT
FAQ
How long has GROUPAMA ASSET MANAGMENT held VRTX?
GROUPAMA ASSET MANAGMENT has disclosed VRTX holdings in 11 of the last 11 reported quarters, going back to Q4 2023.
What is GROUPAMA ASSET MANAGMENT's current position in VRTX?
As of Q2 2026, GROUPAMA ASSET MANAGMENT holds 188.16K shares of VRTX (VERTEX PHARMACEUTICALS INC), valued at $93.87M, representing 1.23% of its reported portfolio and ranking #23.
Has GROUPAMA ASSET MANAGMENT been buying or selling VRTX?
In the latest 13F filing (Q2 2026), GROUPAMA ASSET MANAGMENT increased its position in VRTX. The position peaked in Q2 2026 at 188.16K shares.
Which other funds hold VRTX?
Other major institutional holders of VRTX include Capital World Investors, Capital World Investors, Capital Research Global Investors, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.